You just read:

CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

News provided by

CuraSen Therapeutics, Inc.

Oct 17, 2018, 08:30 ET